Survival of an immuno-competent patient from splenic and gastric mucormycosis-case report and review of the literature - 02/12/21
páginas | 5 |
Iconografías | 0 |
Vídeos | 0 |
Otros | 0 |
Abstract |
Mucormycosis is a life-threatening disease responsible for a high mortality rate. The disease usually affects immuno-compromised patients. While all sites might be involved, gastrointestinal disease is rare, occurring for 5% to 13% of all mucormycosis cases. We report herein the fifth case of splenic and gastric mucormycosis revealed after gastric perforation and the first case occurring among an immuno-competent patient, and we review all reported cases of splenic mucormycosis by searching PubMed publications till October 2020. The literature search yielded 27 cases of splenic mucormycosis including our case. The majority of the cases had underlying immuno-compromised conditions, except for 6 cases, including ours. A male predominance was noted (22 cases). Involvement of the spleen and the stomach was rare, occurring among four immuno-compromised patients. The outcome was death in more than half of the cases. Splenic and gastric mucormycosis is a rare disease. The diagnosis of splenic mucormycosis should be considered in front of splenic lesions suggesting abscess or infarction, especially among immuno-compromised patients.
El texto completo de este artículo está disponible en PDF.Highlights |
• | Splenic mucormycosis occurs mostly among immuno-compromised patients and has a poor prognosis. |
• | Gastric and splenic mucormycosis is a rare disease. Only four cases are reported in the literature. |
• | The diagnosis of gastric mucormycosis should be considered in front of gastric perforation. |
• | The diagnosis of splenic mucormycosis should be considered in front of splenic lesions suggesting abscess or infarction, especially among immuno-compromised patients. |
Keywords : Mucormycosis, Splenic infarction, Gastrointestinal tract, Amphotericin B
Esquema
Vol 31 - N° 4
Artículo 101174- décembre 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?